Case Study: Key Considerations for Developing a Combination Product
Time: 9:00 am
day: Day 2 AM
Details:
- Discussing the development of g-NK cell therapy with antibody combinations for NHL and AML
- Understanding how to navigate regulations and patient treatment procedures with multiple treatment regiments
- Highlighting positive clinical data reinforcing the rationale behind a combination approach
